← Leaderboards
Stephanie Jialing Nakano
University Of Colorado Denver
$981,700
Attributed
$981,700
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243K · FY2017–22$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$981,700 · 2
By mechanism
K08$826,200 · 1
R03$155,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Shelley Deanne Miyamoto$5,520,361
- Carmen C Sucharov$5,015,125
- Brian L Stauffer$5,871,842
- Vitaly Kheyfets$2,451,787
- Clifford R Greyson$1,366,434
Others in their field
Other Emerging Leaders on “Molecular”
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Lynn Briscoe · Leidos Biomedical Research, Inc.$137,360,557
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$109,548,439
- Leonard Freedmand · Leidos Biomedical Research, Inc.$85,594,314
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Scott Hensley · University Of Pennsylvania$41,662,743
Research focus
MolecularPharmaceutical PreparationsHeart FailureMedicalMorphologyPathologicFutureHeartHeart TransplantationInfantCommon VentricleBlood CirculationCalciumMyocardiumCareerAdultCardiacCause Of DeathCardiac MyocytesChildChildhoodImproved OutcomeCardiogenesisPharmacology
Grant awards (7)
Assessing myofilament phenotype and contractile response to pharmacotherapies in a human induced pluripotent stem cell cardiomyocyte (hiPSC-CM) model of hypoplastic left heart syndrome (HLHS)$77,750
R03 · FY2022 · HL · contact PI
Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart Disease$165,240
K08 · FY2021 · HL · contact PI
Assessing myofilament phenotype and contractile response to pharmacotherapies in a human induced pluripotent stem cell cardiomyocyte (hiPSC-CM) model of hypoplastic left heart syndrome (HLHS)$77,750
R03 · FY2021 · HL · contact PI
Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart Disease$165,240
K08 · FY2020 · HL · contact PI
Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart Disease$165,240
K08 · FY2019 · HL · contact PI
Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart Disease$165,240
K08 · FY2018 · HL · contact PI
Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart Disease$165,240
K08 · FY2017 · HL · contact PI